Works matching DE "RIVAROXABAN"
Results: 1508
Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation.
- Published in:
- Journal of Women's Health (15409996), 2017, v. 26, n. 3, p. 214, doi. 10.1089/jwh.2016.5892
- By:
- Publication type:
- Article
Peri-procedural use of direct anticoagulation agents during cardiac device implantation: vitamin K antagonists vs direct oral anticoagulants.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation.
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2014, v. 41, n. 3, p. 231, doi. 10.1007/s10840-014-9948-1
- By:
- Publication type:
- Article
Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2014, v. 41, n. 2, p. 107, doi. 10.1007/s10840-014-9924-9
- By:
- Publication type:
- Article
Development of delayed cardiac tamponade 55 days after catheter ablation for atrial fibrillation with a new oral anticoagulant.
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2014, v. 41, n. 2, p. 135, doi. 10.1007/s10840-014-9926-7
- By:
- Publication type:
- Article
Safety and efficacy of novel oral anticoagulants in the setting of atrial fibrillation ablation: Is it time to celebrate the 'funeral' of warfarin?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Newer clinically available antithrombotics and their antidotes.
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2014, v. 40, n. 3, p. 269, doi. 10.1007/s10840-014-9910-2
- By:
- Publication type:
- Article
Use of Rivaroxaban in Children with Congenital Heart Disease: A Single-Center Case Series.
- Published in:
- Pediatric Cardiology, 2024, v. 45, n. 6, p. 1295, doi. 10.1007/s00246-022-03094-6
- By:
- Publication type:
- Article
Safety of Continuing Anticoagulation Prior to Cardiac Catheterization in Pediatric Patients: A Los Angeles Center Experience.
- Published in:
- Pediatric Cardiology, 2023, v. 44, n. 5, p. 1009, doi. 10.1007/s00246-023-03097-x
- By:
- Publication type:
- Article
Response to letter to the editor and comment concerning "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Comment on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Letter to the editor on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial"
- Published in:
- 2021
- By:
- Publication type:
- Letter
Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial.
- Published in:
- International Orthopaedics, 2020, v. 44, n. 10, p. 2079, doi. 10.1007/s00264-020-04699-3
- By:
- Publication type:
- Article
Treatment appropriateness of direct oral anticoagulants in patients with atrial fibrillation for stroke prevention: A real-world prospective study.
- Published in:
- European Journal of Clinical Pharmacology, 2025, v. 81, n. 1, p. 163, doi. 10.1007/s00228-024-03773-8
- By:
- Publication type:
- Article
Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 8, p. 1141, doi. 10.1007/s00228-024-03689-3
- By:
- Publication type:
- Article
Factor Xa Inhibitors versus warfarin in patients with morbid obesity and atrial fibrillation.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 7, p. 1039, doi. 10.1007/s00228-024-03672-y
- By:
- Publication type:
- Article
Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 797, doi. 10.1007/s00228-024-03648-y
- By:
- Publication type:
- Article
Low-dose Rivaroxaban: is it a safe alternative in Chinese older patients?
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 3, p. 409, doi. 10.1007/s00228-023-03615-z
- By:
- Publication type:
- Article
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 12, p. 1675, doi. 10.1007/s00228-023-03572-7
- By:
- Publication type:
- Article
Prevalence and bleeding risk associated with the concomitant use of direct oral anticoagulants and antiarrhythmic drugs in patients with atrial fibrillation, based on the French healthcare insurance database.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 937, doi. 10.1007/s00228-023-03501-8
- By:
- Publication type:
- Article
Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 9, p. 1521, doi. 10.1007/s00228-022-03357-4
- By:
- Publication type:
- Article
Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 4, p. 557, doi. 10.1007/s00228-022-03280-8
- By:
- Publication type:
- Article
Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 293, doi. 10.1007/s00228-021-03236-4
- By:
- Publication type:
- Article
Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 2, p. 181, doi. 10.1007/s00228-021-03226-6
- By:
- Publication type:
- Article
Direct oral anticoagulant safety during breastfeeding: a narrative review.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1465, doi. 10.1007/s00228-021-03154-5
- By:
- Publication type:
- Article
The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1485, doi. 10.1007/s00228-021-03195-w
- By:
- Publication type:
- Article
Liver injury during rivaroxaban treatment in a patient with AL amyloidosis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Direct acting oral anticoagulants and alopecia: to go further with data mining in pharmacovigilance databases.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 8, p. 1197, doi. 10.1007/s00228-020-02891-3
- By:
- Publication type:
- Article
Direct oral anticoagulants and oesophageal disorders: a pharmacovigilance analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 7, p. 1045, doi. 10.1007/s00228-020-02877-1
- By:
- Publication type:
- Article
Downregulation of ABCB1 gene in patients with total hip or knee arthroplasty influences pharmacokinetics of rivaroxaban: a population pharmacokinetic-pharmacodynamic study.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 6, p. 817, doi. 10.1007/s00228-019-02639-8
- By:
- Publication type:
- Article
Graphical representation of network meta-analysis: an iconographic support to the complexity of multiple data comparisons.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 1, p. 131, doi. 10.1007/s00228-018-2551-0
- By:
- Publication type:
- Article
Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 12, p. 1653, doi. 10.1007/s00228-018-2540-3
- By:
- Publication type:
- Article
Comparative risks of bleeding, ischemic stroke and mortality with direct oral anticoagulants versus phenprocoumon in patients with atrial fibrillation.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 10, p. 1317, doi. 10.1007/s00228-018-2504-7
- By:
- Publication type:
- Article
Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 6, p. 755, doi. 10.1007/s00228-018-2430-8
- By:
- Publication type:
- Article
Residual rivaroxaban exposure after discontinuation of anticoagulant therapy in patients undergoing cardiac catheterization.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 5, p. 611, doi. 10.1007/s00228-018-2421-9
- By:
- Publication type:
- Article
Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 3, p. 323, doi. 10.1007/s00228-017-2374-4
- By:
- Publication type:
- Article
The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillation.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 11, p. 1427, doi. 10.1007/s00228-017-2297-0
- By:
- Publication type:
- Article
Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 11, p. 1417, doi. 10.1007/s00228-017-2296-1
- By:
- Publication type:
- Article
Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 671, doi. 10.1007/s00228-016-2060-y
- By:
- Publication type:
- Article
Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 3, p. 329, doi. 10.1007/s00228-015-1983-z
- By:
- Publication type:
- Article
Rivaroxaban-induced hair loss.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Analgesic use before and after oral anticoagulant initiation-a population-based study in Finland.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 6, p. 723, doi. 10.1007/s00228-015-1836-9
- By:
- Publication type:
- Article
Use of rivaroxaban in Germany: a database drug utilization study of a drug started in hospital.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 8, p. 975, doi. 10.1007/s00228-014-1697-7
- By:
- Publication type:
- Article
Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: the need to manage the introduction of new drugs.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 2, p. 249, doi. 10.1007/s00228-013-1593-6
- By:
- Publication type:
- Article
Novel oral anticoagulants: clinical pharmacology, indications and practical considerations.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 9, p. 1617, doi. 10.1007/s00228-013-1510-z
- By:
- Publication type:
- Article
Concerns about storage and application of dabigatran and rivaroxaban.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Simple and Highly Sensitive UPLC-ESI-MS/MS Assay for Rapid Determination of Suvorexant in Plasma.
- Published in:
- Journal of Analytical Toxicology, 2017, v. 41, n. 2, p. 114, doi. 10.1093/jat/bkw111
- By:
- Publication type:
- Article